MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/110/0.1/21.03.25 Share Price

Warrant

DE000MG39KL1

Market Closed - Börse Stuttgart 19:18:31 14/06/2024 BST
0.07 EUR -1.41% Intraday chart for MORGAN STANLEY PLC/CALL/ASTRAZENECA ADR/110/0.1/21.03.25
Current month+32.08%
1 month+62.79%
Date Price Change
14/06/24 0.07 -1.41%
13/06/24 0.071 -1.39%
12/06/24 0.072 +9.09%
11/06/24 0.066 -4.35%
10/06/24 0.069 +9.52%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 07:18 pm

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying ASTRAZENECA PLC
Issuer Morgan Stanley
WKN MG39KL
ISINDE000MG39KL1
Date issued 30/04/2024
Strike 110 $
Maturity 21/03/2025 (279 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.075
Lowest since issue 0.026
Spread 0.003
Spread %4.05%

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
158.6 USD
Average target price
174.4 USD
Spread / Average Target
+9.95%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW